Xylocaine 2% Jelly contains lidocaine hydrochloride at a concentration of 2% w/v and is a topical local anesthetic indicated for surface anesthesia of mucous membranes. It is commonly used to provide rapid onset of numbness in procedures involving the oropharynx, urethra, or other mucosal surfaces to facilitate minor surgical interventions, endoscopic examinations, catheterization, or diagnostic procedures. Lidocaine acts by stabilizing neuronal membranes and inhibiting the ionic fluxes required for the initiation and conduction of nerve impulses, thereby producing a reversible loss of sensation in the applied area. Xylocaine 2% Jelly offers a viscous formulation that adheres well to mucosal surfaces, ensuring prolonged contact and effective anesthesia. The product is intended for topical application only and should be used with caution to avoid systemic absorption, which may lead to adverse effects such as central nervous system toxicity or cardiovascular disturbances. It is contraindicated in patients with known hypersensitivity to lidocaine or other amide-type local anesthetics. Careful dosing and adherence to recommended guidelines are essential to minimize the risk of toxicity. Xylocaine 2% Jelly is a valuable agent for providing localized anesthesia in various clinical settings requiring mucosal surface anesthesia.